[1]田美花,孟祥达,孙智勇,等.伴有系统性疾病的白内障患者手术疗效及围手术期处理原则[J].眼科新进展,2022,42(1):039-43.[doi:10.13389/j.cnki.rao.2022.0009]
　TIAN Meihua,MENG Xiangda,SUN Zhiyong,et al.Surgical effect for cataract patients with systemic diseases and principles of perioperative management[J].Recent Advances in Ophthalmology,2022,42(1):039-43.[doi:10.13389/j.cnki.rao.2022.0009]
点击复制

伴有系统性疾病的白内障患者手术疗效及围手术期处理原则/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
42卷
期数:
2022年1期
页码:
039-43
栏目:
应用研究
出版日期:
2022-01-05

文章信息/Info

Title:
Surgical effect for cataract patients with systemic diseases and principles of perioperative management
作者:
田美花; 孟祥达; 孙智勇; 于金国; 赫天耕; 韩琪; 陈松; 颜华
300052　天津市，天津医科大学总医院眼科（田美花，孟祥达，孙智勇，于金国，赫天耕，韩琪，陈松，颜华）；300110　天津市，黄河医院（田美花）
Author(s):
TIAN Meihua1; 2; MENG Xiangda1; SUN Zhiyong1; YU Jinguo1; HE Tiangeng1; HAN Qi1; CHEN Song1; YAN Hua1
1.Department of Ophthalmology,Tianjin Medical University General Hospital,Tianjin 300052，China
2.Tianjin Yellow River Hospital,Tianjin 300110，China
关键词:
系统性疾病; 白内障; 超声乳化白内障吸除术; 围手术期处理
Keywords:
systemic diseases;  cataract;  phacoemulsification;  perioperative management
分类号:
R776.1
DOI:
10.13389/j.cnki.rao.2022.0009
文献标志码:
A
摘要:
目的　评价伴有系统性疾病的白内障患者行超声乳化白内障吸除联合人工晶状体植入术的安全性、疗效和围手术期处理原则。方法　选取2018年5月至2020年5月于天津医科大学总医院眼科诊断为白内障并伴有系统性疾病且接受超声乳化白内障吸除联合人工晶状体植入术的患者401例(499眼)为研究对象，加强术前围手术期管理，术后随访至少3个月，对比观察术前及术后患者最佳矫正视力(BCVA)、眼压、角膜内皮细胞数，并分析眼部并发症与系统性疾病的关系。结果　术后3个月，BCVA较术前提高者481眼(96.39％)，不变者12眼(2.40％)，下降者6眼(1.20%)。术前眼压为（16.64±4.76）mmHg（1 kPa=7.5 mmHg)，术后3个月为（15.79±5.98）mmHg，差异具有统计学意义(t=2.710，P<0.05)。术前角膜内皮细胞数为（2523.80±469.52)个·mm-2，术后3个月为（2245.56±469.94)个·mm-2，差异具有统计学意义(Z=-17.307，P<0.05)。术后并发症主要包括：一过性角膜水肿168眼(33.67%)、一过性高眼压63眼(12.63%)、一过性低眼压7眼(1.40%)、前房渗出14眼(2.81%)。通过分类变量分析，2型糖尿病、尿毒症与术后一过性高眼压均相关(均为P<0.05)；冠心病与术后一过性低眼压相关(P<0.05)；2型糖尿病、高血压、冠心病、尿毒症、系统性红斑狼疮与术后一过性角膜水肿均相关(均为P<0.05)；系统性红斑狼疮与术后前房渗出相关(P<0.05)。术后随访期内患者系统性疾病均稳定。结论　超声乳化白内障吸除联合人工晶状体植入术是治疗伴有系统性疾病的白内障患者安全有效的方法。术前完善全身相关检查并控制系统性疾病是安全完成手术的基础。
Abstract:
Objective　To evaluate the safety, efficacy and perioperative management principles of phacoemulsification combined with intraocular lens implantation in cataract patients with systemic diseases.Methods　A total of 401 cataract patients (499 eyes) with systemic diseases that underwent phacoemulsification combined with intraocular lens implantation in Tianjin Medical University General Hospital from May 2018 to May 2020 were selected in this study. All eyes received preoperative and postoperative examinations, including best corrected visual acuity (BCVA), intraocular pressure (IOP), and corneal endothelial cell counts. All patients were followed up for at least 3 months. The relationship between ocular complications and systemic diseases was analyzed.Results　Postoperatively, 481 eyes’ (96.39%) BCVA improved, 12 eyes’ (2.40%) BCVA remained unchanged, and 6 eyes’ (1.20%) BCVA decreased at 3 months after surgery. The mean IOP at 3 months postoperative was significantly reduced compared with the preoperative measurement ［(15.79±5.98) mmHg versus (16.64±4.76) mmHg, 1 kPa=7.5 mmHg］, and the difference was statistically significant (t=2.710, P<0.05). The density of corneal endothelial cells at 3 months postoperative was also decreased compared with the preoperative measurement ［(2245.56±469.94)mm-2 versus (2523.80±469.52)mm-2］, and the difference was statistically significant (Z=-17.307, P<0.05). Postoperative complications mainly included transient corneal edema (168 eyes, 33.67%), transient high IOP (63 eyes, 12.63%), transient low IOP (7 eyes, 1.40%), and anterior chamber exudation (14 eyes, 2.81%). Through analysis of categorical variables, type 2 diabetes and uremia were found to be associated with transient high IOP postoperatively (both P<0.05), and coronary heart disease (CHD) was associated with transient low IOP postoperatively (P<0.05). Type 2 diabetes, hypertension, CHD, uremia, and systemic lupus erythematosus were associated with transient corneal edema postoperatively (all P<0.05), and systemic lupus erythematosus was also associated with anterior chamber exudation postoperatively (P<0.05). Patients’ systemic diseases were stable during the postoperative follow-up period.Conclusion　Phacoemulsification combined with intraocular lens implantation is a safe and effective method for the treatment of cataract patients with systemic diseases. Preoperative systemic examinations and control of systemic diseases are important for the success of cataract surgery.

参考文献/References:

［1］　MUTOH T,ISOME S,MATSUMOTO Y,CHIKUDA M.Cataract surgery in patients older than 90 years of age［J］.Can J Ophthalmol,2012,47(2):140-144.
［2］　VOHRA R,TSAI J C,KOLKO M.The role of inflammation in the pathogenesis of glaucoma ［J］.Surv Ophthalmol,2013,58(4):311-320.
［3］　SHEPARD A R,MILLAR J C,PANG I H,JACOBSON N,WANG W H,CLARK A F.Adenoviral gene transfer of active human transforming growth factor-beta 2 elevates intraocular pressure and reduces outflow facility in rodent eyes［J］.Invest Ophthalmol Vis Sci,2010,51(4):2067-2076.
［4］　PARK C H,KIM J W.Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells［J］.Korean J Ophthalmol,2012,26(2):123-131.
［5］　MOON J J,KIM Y W,OH B L,HAN K,KIM D K,JOO K W,et al.Nationwide glaucoma incidence in end stage renal disease patients and kidney transplant recipients［J］.Sci Rep,2021,11(1):7418.
［6］　LIM C C,LEE C Y,HUANG F C,HUANG J Y,HUNG J H,YANG S F.Risk of glaucoma in patients receiving hemodialysis and peritoneal dialysis:a nationwide population-based cohort study［J］.Int J Environ Res Public Health,2020,17(18):6774.
［7］　TOKUYAMA T,IKEDA T,SATO K.Effect of plasma colloid osmotic pressure on intraocular pressure during haemodialysis［J］.Br J Ophthalmol,1998,82(7):751-753.
［8］　CHUNG H J,HWANG H B,LEE N Y.The association between primary open-angle glaucoma and blood pressure:two aspects of hypertension and hypotension［J］.Biomed Res Int,2015,2015:827516.
［9］　KLEIN B E,KLEIN R,KNUDTSON M D.Intraocular pressure and systemic blood pressure:iongitudinal perspective:the Beaver Dam Eye Study［J］.Br J Ophthalmol,2005,89(3):284-287.
［10］　LEE Y W,MIN W K,CHUN S,LEE W,KIM Y,CHUN S H,et al.The association between intraocular pressure and predictors of coronary heart disease risk in Koreans［J］.J Korean Med Sci,2008,23(1):31-34.
［11］　LEAL I,CHU C J,YANG Y Y,MANASSES D M,SEBASTIAN R T,SPARROW J M.Intraocular pressure reduction after real-world cataract surgery［J］.J Glaucoma,2020,29(8):689-693.
［12］　SHRIVASTAVA A,SINGH K.The effect of cataract extraction on intraocular pressure［J］.Curr Opin Ophthalmol,2010,21(2):118-122.
［13］　KHOSLA U M,ZHARIKOV S,FINCH J L,NAKAGAWA T,RONCAL C,MU W,et al.Hyperuricemia induces endothelial dysfunction［J］.Kidney Int,2005,67(5):1739-1742.
［14］　COASSIN M,PIOVANETTI O,STARK W J,GREEN W R.Urate deposition in the iris and anterior chamber［J］.Ophthalmology,2006,113(3):462-465.
［15］　SOLER N,ROMERO-AROCA P,GRIS O,CAMPS J,FERNANDEZ-BALLART J.Corneal endothelial changes in patients with chronic obstructive pulmonary disease and corneal vulnerability to cataract surgery［J］.J Cataract Refract Surg,2015,41(2):313-319.
［16］　王霜宁.角膜内皮功能紊乱的易患因素 ［J］.中华实验眼科杂志,2017,35(7):669-672.
WANG S N.Risk factors for corneal endothelium dysfunction［J］.Chin J Exp Ophthalmol,2017,35(7):669-672.
［17］　YIN S,ZHANG J,HUA X,HUANG G,JIA B,LIU Y,et al.Analysis of factors associated with vision after cataract surgery in chronic renal failure patients on dialysis［J］.BMC Ophthalmol,2020,20(1):211.
［18］　BOJARUN A,VIEVERSYTE Z,JARUSEVICIENE R,GALGAUSKAS S,ASOKLIS R,ZABLOCKIS R.Effect of obstructive sleep apnea on corneal morphological characteristics［J］.Cornea,2019,38(12):1576-1581.
［19］　KUVER R,SAVARD C,ODA D,LEE S P.PGE generates intracellular cAMP and accelerates mucin secretion by cultured dog gallbladder epithelial cells［J］.Am J Physiol,1994,267(6 Pt 1):G998-G1003.
［20］　李朝辉,马天驹,叶子.重视合并糖尿病的白内障患者管理 ［J］.中华眼科杂志,2020,56(5):325-329.
LI Z H,MA T J,YE Z.Properly managing the cataract patients with diabetes mellitus［J］.Chin J Ophthalmol,2020,56(5):325-329.
［21］　HSU C S,HSU C W,LU M C,KOO M.Risks of ophthalmic disorders in patients with systemic lupus erythematosus - a secondary cohort analysis of population-based claims data［J］.BMC Ophthalmol,2020,20(1):96.
［22］　BAREQUET I S,SACHS D,SHENKMAN B,PRIEL A,WASSERZUG Y,BUDNIK I,et al.Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy［J］.J Cataract Refract Surg,2011,37(8):1434-1438.
［23］　KATZ J,FELDMAN M A,BASS E B,LUBOMSKI L H,TIELSCH J M,PETTY B G,et al.Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery［J］.Ophthalmology,2003,110(9):1784-1788.
［24］　NEUHAUS O,KFER G.Essential thrombocytosis 40 years after splenectomy［J］.BMJ Case Rep,2018,2018:bcr2017223959.
［25］　中华医学会血液学分会血栓与止血学组,中国血友病协作组.血友病治疗中国指南（2020年版） ［J］.中华血液学杂志,2020,41(4):265-271.
Thrombosis and Hemostasis Group,Chinese Society of Hematology,Chinese Medical Association/Hemophilia Treatment Center Collaborative Network of China.Chinese guidelines on the treatment of hemophilia (version 2020) ［J］.Chin J Hematol,2020,41(4):265-271.
［26］　胡健,彭捷,阳红斌,傅敢，赵谢兰，李晓林.血友病A患者围手术期凝血因子Ⅷ替代治疗的疗效评价 ［J］.中国药师,2018,21(7):1199-1201.
HU J,PENG J,YANG H B,FU G,ZHAO X L,LI X L.Efficacy evaluation of perioperative coagulation factor Ⅷ replacement therapy for hemophilia a patients with surgery［J］.Chin Pharm,2018,21(7):1199-1201.
［27］　韩琪,张静楷,于金国,韩金栋，颜华.甲型血友病患者内眼手术一例 ［J］.中华眼科杂志,2009,45(5):461-462.
HAN Q,ZHANG J K,YU J G,HAN J D,YAN H.A case of intraocular surgery in a patient with hemophilia A ［J］.Chin J Ophthalmol,2009,45(5):461-462.

相似文献/References:

[1]乔建治 张永喜.抗青光眼术后白内障行不同切口超声乳化术的临床疗效分析[J].眼科新进展,2012,32(4):000.
[2]吴星.年龄相关性白内障患者超声乳化手术前后对比敏感度分析[J].眼科新进展,2012,32(6):000.
[3]王勇 叶应嘉 鲍先议 周龑丽 许荣 彭婷婷 曾志富.同轴微小切口超声乳化吸出术在青光眼滤过术后白内障摘出术中的应用[J].眼科新进展,2012,32(7):000.
[4]徐威.注射器针头囊袋内吸附劈核法在白内障手术中的应用[J].眼科新进展,2012,32(7):000.
[5]冉文瑛 陈静 张树利.抗青光眼术后不同角膜切口白内障超声乳化术对角膜屈光状态的影响[J].眼科新进展,2012,32(7):000.
[6]王运.常规连续模式超声乳化术与爆破模式冷超声乳化术治疗白内障的临床疗效比较[J].眼科新进展,2012,32(11):000.
[7]郭照洪 王宏 宋爱平 文译 侯祺 解柳.超声乳化白内障摘出联合人工晶状体植入治疗超高度轴性近视白内障患者的临床疗效[J].眼科新进展,2013,33(1):000.
[8]刘珣 王欣玲 柏全豪 张劲松 阎启昌.IOLMaster与四种人工晶状体屈光度计算公式的准确性研究[J].眼科新进展,2013,33(2):000.
[9]张灿伟 黄旭东 姜雅琴 高婧 孙先勇 张杰 任建涛.α晶状体蛋白抗体与超声乳化术后前房炎症反应的相关性[J].眼科新进展,2013,33(6):000.
[10]唐东永 李霞 梁皓 何剑 谭少健.应用超声生物显微镜观察Bigbag人工晶状体在高度近视眼囊袋内的稳定性[J].眼科新进展,2013,33(6):000.

备注/Memo

备注/Memo:
国际(地区)合作与交流项目(编号：82020108007)；国家自然科学基金重点项目(编号：81830026)；京津冀专项项目［编号：19JCZDJC64300(Z)］
更新日期/Last Update: 2022-01-05